HMOX1 and Alzheimer disease: Exosome‐like nanoparticles derived from Lycium ruthenicum (LRM‐ELNs) significantly reduce Aβ‐induced oxidative stress in HT22 cells by activating the Nrf2/HO‐1/NQO1 signaling pathway, suggesting their potential for Alzheimer's disease (AD) therapy (Y. Zhang et al. 2024).